← All companies

KROS

Keros Therapeutics, Inc.

KROS Nasdaq Pharmaceutical Preparations EDGAR ↗

$10.11

-0.11 -1.08%

Key statistics

from XBRL data in SEC filings

Market cap

$200M

Revenue (TTM)

$15.0M

Net income (TTM)

-$83.2M

EPS (TTM)

$-3.22

P/E ratio

—

Dividend yield

—

Free cash flow

$106M

Cash

$258M

Total assets

$288M

Gross margin

—

52-week range

$9.69 – $22.55

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Aug 3, 2026 10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Regulation FD disclosure Jul 30, 2026 8-K Director or officer change Jul 22, 2026 8-K Director or officer change; Regulation FD disclosure Jun 25, 2026 8-K Shareholder vote results Jun 3, 2026 8-K Regulation FD disclosure Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Other events Mar 9, 2026 8-K Regulation FD disclosure Mar 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Results of operations (earnings release) Mar 4, 2026 8-K Director or officer change; Regulation FD disclosure Feb 26, 2026 8-K Regulation FD disclosure Feb 18, 2026 8-K Regulation FD disclosure Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Results of operations (earnings release); Director or officer change; Regulation FD disclosure; Other events Oct 15, 2025 8-K Other events Sep 8, 2025 8-K Regulation FD disclosure Aug 28, 2025 8-K Other events Aug 20, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Other events Jul 17, 2025 8-K Director or officer change Jul 15, 2025 8-K Shareholder vote results; Other events Jun 9, 2025 8-K Regulation FD disclosure Jun 6, 2025 8-K Exit or disposal costs; Other events May 29, 2025 8-K Regulation FD disclosure May 12, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Entered a material agreement Apr 18, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events Apr 10, 2025 8-K Other events Mar 31, 2025 8-K Amended charter or bylaws Mar 6, 2025 8-K Regulation FD disclosure Feb 28, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025